Difference between revisions of "Template:Glutamate receptor modulators"
Jump to navigation
Jump to search
| Line 47: | Line 47: | ||
* [[Sunifiram]] | * [[Sunifiram]] | ||
* [[Unifiram]] | * [[Unifiram]] | ||
| + | |||
* '''Antagonists:''' [[ACEA-1011]] | * '''Antagonists:''' [[ACEA-1011]] | ||
* [[ATPO]] | * [[ATPO]] | ||
| Line 296: | Line 297: | ||
* [[Halothane]] | * [[Halothane]] | ||
* [[Isoflurane]] | * [[Isoflurane]] | ||
| + | |||
* '''Antagonists:''' [[ACEA-1011]] | * '''Antagonists:''' [[ACEA-1011]] | ||
* [[CNQX]] | * [[CNQX]] | ||
| Line 328: | Line 330: | ||
* [[Ro67-7476]] | * [[Ro67-7476]] | ||
* [[VU-71]] | * [[VU-71]] | ||
| + | |||
* '''Antagonists:''' [[BAY 36-7620]] | * '''Antagonists:''' [[BAY 36-7620]] | ||
* [[CPCCOEt]] | * [[CPCCOEt]] | ||
| Line 351: | Line 354: | ||
* [[Pomaglumetad methionil|Pomaglumetad methionil (LY-2140023)]] | * [[Pomaglumetad methionil|Pomaglumetad methionil (LY-2140023)]] | ||
* [[Talaglumetad]]; ''Positive allosteric modulators:'' [[JNJ-40411813|JNJ-40411813 (ADX-71149)]] | * [[Talaglumetad]]; ''Positive allosteric modulators:'' [[JNJ-40411813|JNJ-40411813 (ADX-71149)]] | ||
| + | |||
* '''Antagonists:''' [[APICA (drug)|APICA]] | * '''Antagonists:''' [[APICA (drug)|APICA]] | ||
* [[CECXG]] | * [[CECXG]] | ||
| Line 375: | Line 379: | ||
* [[Pomaglumetad methionil|Pomaglumetad methionil (LY-2140023)]] | * [[Pomaglumetad methionil|Pomaglumetad methionil (LY-2140023)]] | ||
* [[Talaglumetad]] | * [[Talaglumetad]] | ||
| + | |||
* '''Antagonists:''' [[APICA (drug)|APICA]] | * '''Antagonists:''' [[APICA (drug)|APICA]] | ||
* [[CECXG]] | * [[CECXG]] | ||
| Line 392: | Line 397: | ||
* [[VU-001,171]] | * [[VU-001,171]] | ||
* [[VU-0155,041]]; ''Positive allosteric modulators:'' [[2-Methyl-6-(phenylethynyl)pyridine|MPEP]] | * [[VU-0155,041]]; ''Positive allosteric modulators:'' [[2-Methyl-6-(phenylethynyl)pyridine|MPEP]] | ||
| + | |||
* '''Antagonists:''' [[CPPG]] | * '''Antagonists:''' [[CPPG]] | ||
* [[MAP4 (drug)|MAP4]] | * [[MAP4 (drug)|MAP4]] | ||
| Line 411: | Line 417: | ||
* [[Quisqualic acid]] | * [[Quisqualic acid]] | ||
* [[VU-1545]] | * [[VU-1545]] | ||
| + | |||
* '''Antagonists:''' [[CTEP]] | * '''Antagonists:''' [[CTEP]] | ||
* [[DMeOB]] | * [[DMeOB]] | ||
| Line 431: | Line 438: | ||
* '''Agonists:''' [[Glutamate]] | * '''Agonists:''' [[Glutamate]] | ||
* [[L-AP4|<small>L</small>-AP4]] | * [[L-AP4|<small>L</small>-AP4]] | ||
| + | |||
* '''Antagonists:''' [[CPPG]] | * '''Antagonists:''' [[CPPG]] | ||
* [[MAP4 (drug)|MAP4]] | * [[MAP4 (drug)|MAP4]] | ||
| Line 443: | Line 451: | ||
* [[Glutamate]] | * [[Glutamate]] | ||
* [[L-AP4|<small>L</small>-AP4]] | * [[L-AP4|<small>L</small>-AP4]] | ||
| + | |||
* '''Antagonists:''' [[CPPG]] | * '''Antagonists:''' [[CPPG]] | ||
* [[MAP4 (drug)|MAP4]] | * [[MAP4 (drug)|MAP4]] | ||
| Line 456: | Line 465: | ||
* [[Glutamate]] | * [[Glutamate]] | ||
* [[L-AP4|<small>L</small>-AP4]] | * [[L-AP4|<small>L</small>-AP4]] | ||
| + | |||
* '''Antagonists:''' [[CPPG]] | * '''Antagonists:''' [[CPPG]] | ||
* [[MAP4 (drug)|MAP4]] | * [[MAP4 (drug)|MAP4]] | ||
| Line 583: | Line 593: | ||
* '''Precursors:''' [[γ-Hydroxybutyric acid|GHB]]<!--PMID: 10381791--> | * '''Precursors:''' [[γ-Hydroxybutyric acid|GHB]]<!--PMID: 10381791--> | ||
* [[Glutamine|<small>L</small>-Glutamine]] | * [[Glutamine|<small>L</small>-Glutamine]] | ||
| + | |||
* '''Cofactors:''' [[α-Ketoglutaric acid]] | * '''Cofactors:''' [[α-Ketoglutaric acid]] | ||
* [[Iron]] | * [[Iron]] | ||
| Line 588: | Line 599: | ||
* [[Vitamin B2|Vitamin B<sub>2</sub>]] | * [[Vitamin B2|Vitamin B<sub>2</sub>]] | ||
* [[Vitamin B3|Vitamin B<sub>3</sub>]] | * [[Vitamin B3|Vitamin B<sub>3</sub>]] | ||
| + | |||
* '''Others:''' [[Acamprosate]] | * '''Others:''' [[Acamprosate]] | ||
* [[Cysteine]] | * [[Cysteine]] | ||
Revision as of 09:11, 28 January 2016
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Glutamate receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Glutamate receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Glutamate receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.
